Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit
Interview with the Chairman and CEO: Intrexon Corporation (NYSE:XON)
March 16, 2018
Kirk, Randal J.
Downturn in Biotech Creates Opportunities for Investors to Realize Superior Gains
April 21, 2017
Markey, Keith A.
Looking for Sustainable Improvement in Biotechnology Valuations
January 15, 2016
Markey, Keith A.
James Awad - Awad Asset Management
September 16, 2002
Awad, James D.
J. Alan Day - The Stratavest Group
December 20, 1999
Day, J. Alan
E. Greg Mccartney - Biolabs Inc (bilb.to)
December 13, 1999
McCartney, E. Greg
Richard L. Babson - Babson-united Inc
December 06, 1999
Babson, Richard L.
James E. Wiggins - Phronesis Partners
November 08, 1999
Wiggins, James E.
John P. Waterman - Rittenhouse Financial Services
November 01, 1999
McCandless, Leonard H., Waterman, John P.
George B. Wallace - Micro Therapeutics Inc (mtix)
September 30, 1999
Wallace, George B.
Eric S. Ende - First Pacific Advisors
September 27, 1999
Ende, Eric S.
Mark Ansell - Aston Villa Plc (asv.l)
September 06, 1999
Ansell, Mark
Alan N. Hoffman - Value Line Asset Management
December 28, 1998
Hoffman, Alan N.
Practice Management : Lawrence C. Marsh - Salomon Smith Barney
December 14, 1998
Marsh, Lawrence C.
Semiconductor Industry Outlook : Drew Peck - S.g. Cowen Securities
November 02, 1998
Peck, Drew
Timothy H. Foster - Bradley, Foster & Sargent Inc
October 19, 1998
Foster, Timothy H.
Wayne F. Wilbanks - Wilbanks, Smith & Thomas
September 07, 1998
Wilbanks, Wayne F.
Brokers & Asset Managers : Joan Solotar - Donaldson Lufkin & Jenrette
July 20, 1998
Solotar, Joan
